PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Research Scholar, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies, 600117, Chennai, India. Electronic address: praveennandan.1993@gmail.com.\', \'Research Scholar, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies, 600117, Chennai, India. Electronic address: ranadheer.pharmd@gmail.com.\', \'Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies, Chennai, India. Electronic address: hodpchemistry@velsuniv.ac.in.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0924-8579(20)30124-210.1016/j.ijantimicag.2020.105967
?:hasPublicationType
?:journal
  • International journal of antimicrobial agents
is ?:pmid of
?:pmid
?:pmid
  • 32259575
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 107
is ?:relation_isRelatedTo_publication of
?:title
  • Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32259575>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32259575>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all